Morning Overview on MSN
New prostate cancer cell atlas may aid earlier detection, researchers say
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management.
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...
Add Yahoo as a preferred source to see more of our stories on Google. A major international trial finds that adding niraparib to standard prostate cancer therapy delays disease progression. (CREDIT: ...
A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Patches that lower testosterone by delivering oestradiol, a form of oestrogen, through the skin were just as effective as injections at preventing the cancer from spreading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results